Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Titel:
Nanostructured lipid carriers based mRNA vaccine leads to a T cell–inflamed tumour microenvironment favourable for improving PD-1/PD-L1 blocking therapy and long-term immunity in a cold tumour model
Auteur:
Fournier, Carole Mercey-Ressejac, Marion Derangère, Valentin Al Kadi, Amal Rageot, David Charrat, Christine Leroy, Alexis Vollaire, Julien Josserand, Véronique Escudé, Marie Escaich, Séverine Ghiringhelli, François Decaens, Thomas Navarro, Fabrice P. Jouvin-Marche, Evelyne Marche, Patrice N.